GPCRVSMRNA• 28 Days (Normalized)
GPCR vs MRNA (Structure Therapeutics Inc. vs Moderna Inc.)
Showing Closing Date Range from Aug, 19 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GPCR Performance $36.37
-32.81%
Structure Therapeutics Inc.
Normalized Baseline0.00%
MRNA Performance $146.94
-15.74%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-17.07%
MRNA outperforming by 17.07%
GPCRMRNA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GPCR MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | GPCR Price | GPCR Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $36.37 | -32.81% | $146.94 | -15.74% | -17.07% |
| Sep 15, 2026 | $38.95 | -28.04% | $143.77 | -17.55% | -10.49% |
| Sep 14, 2026 | $38.44 | -28.99% | $146.69 | -15.88% | -13.11% |
| Sep 11, 2026 | $38.66 | -28.58% | $143.97 | -17.44% | -11.14% |
| Sep 10, 2026 | $39.55 | -26.94% | $136.62 | -21.65% | -5.29% |
| Sep 09, 2026 | $41.23 | -23.83% | $135.61 | -22.23% | -1.60% |
| Sep 08, 2026 | $40.38 | -25.40% | $140.33 | -19.53% | -5.87% |
| Sep 04, 2026 | $47.34 | -12.54% | $145.55 | -16.53% | +3.99% |
| Sep 03, 2026 | $47.34 | -12.54% | $148.87 | -14.63% | +2.09% |
| Sep 02, 2026 | $47.80 | -11.69% | $150.81 | -13.52% | +1.83% |
| Sep 01, 2026 | $47.13 | -12.93% | $154.27 | -11.53% | -1.40% |
| Aug 31, 2026 | $45.91 | -15.19% | $140.34 | -19.52% | +4.33% |
| Aug 28, 2026 | $47.37 | -12.49% | $137.99 | -20.87% | +8.38% |
| Aug 27, 2026 | $49.22 | -9.07% | $142.77 | -18.13% | +9.06% |
| Aug 26, 2026 | $49.35 | -8.83% | $149.66 | -14.18% | +5.35% |
Page 1 of 2